Quick Answer
AYTU BIOPHARMA, INC reported Long Term Debt of $10.88 million for the year ending 2024.
- AYTU BIOPHARMA, INC showed a decrease of -26.1% in Long Term Debt from 2023 to 2024.
- This data is from AYTU BIOPHARMA, INC's annual report (Form 10-K), filed with the SEC on September 26, 2024.
- XBRL data for this metric is available from 2023 to 2024 (2 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2018: $0.00 | Q4 2018: $5.04 million | Q1 2019: $5.13 million | Q2 2019: $0.00 | Q4 2019: $23.39 million | Q1 2020: $8.16 million | Q4 2023: $14.98 million | Q1 2024: $0.00 | Q2 2024: $10.88 million | Q3 2024: $10.43 million | Q4 2024: $9.98 million.
- Historical annual values: Fiscal year 2024: $10.88 million | Fiscal year 2023: $14.71 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: